FDA Enforcement Class III Terminated

LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit Catalog #: L016080109002 (EUA) The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip. The Quality Controls provide users with assurance that the device is performing within specification

Recall: Z-0135-2023 · Reported November 2, 2022

Enforcement

Recall Number
Z-0135-2023
Event ID
90998
Classification
Class III
Status
Terminated
Product Type
Devices
Firm
LumiraDx
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
November 2, 2022
Initiation Date
September 23, 2022
Classification Date
October 26, 2022
Termination Date
December 13, 2024
Address
221 Crescent St, N/A, Waltham, MA, 02453-3475, United States

Description

LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit Catalog #: L016080109002 (EUA) The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip. The Quality Controls provide users with assurance that the device is performing within specification

Reason

Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 Ag LQCs within batch 2002204017, which should have been assigned SARS-CoV-2 Ag lot numbers resulting in an error message and preventing use of the LQC

Code Info

LQC Kit: 2002204017 Positive Control Vial: 1000 1710 0014 0141 Negative Control Vial: 1000 1720 0014 0142 Exp. Date: 01-Mar-2023

Distribution

US Nationwide distribution.

Quantity

83 kits